Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 527,100 | 489,000 | 479,900 | 463,900 | 513,800 |
| Cost of Goods | 347,100 | 329,000 | 304,400 | 313,300 | 326,600 |
| Gross Profit | 180,000 | 160,000 | 175,500 | 150,600 | 187,200 |
| Operating Expenses | 86,600 | 82,600 | 85,800 | 86,700 | 86,300 |
| Operating Income | 93,500 | 77,400 | 90,100 | 64,200 | 101,500 |
| Interest Expense | 3,000 | 3,200 | 3,200 | 3,400 | 4,800 |
| Other Income | 0 | -600 | 1,000 | -300 | -7,700 |
| Pre-tax Income | 90,500 | 73,600 | 87,900 | 60,500 | 89,000 |
| Income Tax | 28,000 | 17,700 | 31,900 | 16,100 | 26,400 |
| Net Income Continuous | 62,500 | 55,900 | 56,000 | 44,400 | 62,600 |
| Net Income Discontinuous | 11,100 | N/A | 3,500 | -600 | -28,000 |
| Net Income | $73,600 | $55,900 | $59,500 | $43,800 | $34,600 |
| EPS Basic Total Ops | 1.02 | 0.78 | 0.78 | 0.60 | 0.43 |
| EPS Basic Continuous Ops | 0.86 | 0.78 | 0.71 | 0.61 | 0.77 |
| EPS Basic Discontinuous Ops | 0.16 | N/A | 0.07 | -0.01 | -0.34 |
| EPS Diluted Total Ops | 1.00 | 0.76 | 0.77 | 0.59 | 0.42 |
| EPS Diluted Continuous Ops | 0.85 | 0.76 | 0.69 | 0.60 | 0.76 |
| EPS Diluted Discontinuous Ops | 0.15 | N/A | 0.08 | -0.01 | -0.34 |
| EBITDA(a) | $113,600 | $96,800 | $107,000 | $83,400 | $120,800 |